11/13
09:00 am
ipa
$20 Billion Market Breakthrough: IPA Pioneers High-Impact Antibody Development for Next-Generation ADC Cancer Therapies
High
Report
$20 Billion Market Breakthrough: IPA Pioneers High-Impact Antibody Development for Next-Generation ADC Cancer Therapies
11/4
08:08 am
ipa
ImmunoPrecise to Host TECHDAY: Cutting-Edge AI and Biologics Innovation [Yahoo! Finance]
Low
Report
ImmunoPrecise to Host TECHDAY: Cutting-Edge AI and Biologics Innovation [Yahoo! Finance]
11/4
08:01 am
ipa
ImmunoPrecise to Host TECHDAY: Cutting-Edge AI and Biologics Innovation
Low
Report
ImmunoPrecise to Host TECHDAY: Cutting-Edge AI and Biologics Innovation
10/28
07:30 am
ipa
ImmunoPrecise Advances Anti-Aging Research with Mayo Clinic Study, Poised to Tap into $81 Billion Market with AI Technology
High
Report
ImmunoPrecise Advances Anti-Aging Research with Mayo Clinic Study, Poised to Tap into $81 Billion Market with AI Technology
10/21
09:00 am
ipa
ImmunoPrecise Antibodies to Participate at the AI Driven Drug Discovery Summit USA 2024
Low
Report
ImmunoPrecise Antibodies to Participate at the AI Driven Drug Discovery Summit USA 2024
10/10
08:21 am
ipa
ImmunoPrecise Antibodies Celebrates Nobel Prize in Chemistry, Advances in AI-Powered Protein Design [Yahoo! Finance]
Low
Report
ImmunoPrecise Antibodies Celebrates Nobel Prize in Chemistry, Advances in AI-Powered Protein Design [Yahoo! Finance]
10/10
08:10 am
ipa
ImmunoPrecise Antibodies Celebrates Nobel Prize in Chemistry, Advances in AI-Powered Protein Design
Medium
Report
ImmunoPrecise Antibodies Celebrates Nobel Prize in Chemistry, Advances in AI-Powered Protein Design
10/3
07:49 am
ipa
ImmunoPrecise and Biotheus partner on bispecific antibodies to treat cancer [Yahoo! Finance]
Medium
Report
ImmunoPrecise and Biotheus partner on bispecific antibodies to treat cancer [Yahoo! Finance]
10/2
08:00 am
ipa
ImmunoPrecise Subsidiary Signs Material Transfer Agreement with Biotheus
Low
Report
ImmunoPrecise Subsidiary Signs Material Transfer Agreement with Biotheus
9/26
09:00 am
ipa
ImmunoPrecise Antibodies Advances Therapeutic Innovation with Groundbreaking Rabbit Antibody Developments
Medium
Report
ImmunoPrecise Antibodies Advances Therapeutic Innovation with Groundbreaking Rabbit Antibody Developments
9/17
08:02 am
ipa
ImmunoPrecise Antibodies Ltd. (NASDAQ: IPA) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $9.00 price target on the stock.
Low
Report
ImmunoPrecise Antibodies Ltd. (NASDAQ: IPA) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $9.00 price target on the stock.
9/16
02:41 pm
ipa
ImmunoPrecise Antibodies Ltd. (IPA) Q1 2025 Earnings Call Transcript [Seeking Alpha]
Low
Report
ImmunoPrecise Antibodies Ltd. (IPA) Q1 2025 Earnings Call Transcript [Seeking Alpha]
9/16
09:00 am
ipa
ImmunoPrecise Antibodies (IPA) Reports Financial Results and Recent Business Highlights for First Quarter Fiscal Year 2025
High
Report
ImmunoPrecise Antibodies (IPA) Reports Financial Results and Recent Business Highlights for First Quarter Fiscal Year 2025
9/9
09:14 am
ipa
IPA to Report Financial Results and Recent Business Highlights for First Quarter Fiscal Year 2025 on September 16, 2024 [Yahoo! Finance]
Low
Report
IPA to Report Financial Results and Recent Business Highlights for First Quarter Fiscal Year 2025 on September 16, 2024 [Yahoo! Finance]
9/9
09:11 am
ipa
IPA to Report Financial Results and Recent Business Highlights for First Quarter Fiscal Year 2025 on September 16, 2024
Medium
Report
IPA to Report Financial Results and Recent Business Highlights for First Quarter Fiscal Year 2025 on September 16, 2024
8/26
09:00 am
ipa
ImmunoPrecise Antibodies to Participate at H.C. Wainwright's 26th Annual Global Investment Conference in New York
Low
Report
ImmunoPrecise Antibodies to Participate at H.C. Wainwright's 26th Annual Global Investment Conference in New York
8/23
08:03 pm
ipa
ImmunoPrecise Antibodies Receives Nasdaq Notification Regarding Minimum Bid Requirements [Yahoo! Finance]
Low
Report
ImmunoPrecise Antibodies Receives Nasdaq Notification Regarding Minimum Bid Requirements [Yahoo! Finance]
8/23
08:00 pm
ipa
ImmunoPrecise Antibodies Receives Nasdaq Notification Regarding Minimum Bid Requirements
Low
Report
ImmunoPrecise Antibodies Receives Nasdaq Notification Regarding Minimum Bid Requirements